Trial Outcomes & Findings for Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits (NCT NCT04328207)
NCT ID: NCT04328207
Last Updated: 2025-08-07
Results Overview
The percentage of patients who adhere to attending their referral appointments who received a financial incentive and eye health education will be compared with the percentage of patients who adhere to attending their referral appointments who received standard of care eye health education alone and no financial incentive for completing a referral visit.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
900 participants
Primary outcome timeframe
The time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date.
Results posted on
2025-08-07
Participant Flow
Participant milestones
| Measure |
No Financial Incentive
This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
No Financial Incentive: Standard of care eye health education
|
Financial Incentive
This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.
Financial Incentive: Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
|
|---|---|---|
|
Overall Study
STARTED
|
499
|
401
|
|
Overall Study
COMPLETED
|
499
|
401
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits
Baseline characteristics by cohort
| Measure |
No Financial Incentive
n=499 Participants
This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
No Financial Incentive: Standard of care eye health education
|
Financial Incentive
n=401 Participants
This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.
Financial Incentive: Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
|
Total
n=900 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
272 Participants
n=99 Participants
|
200 Participants
n=107 Participants
|
472 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
227 Participants
n=99 Participants
|
201 Participants
n=107 Participants
|
428 Participants
n=206 Participants
|
|
Age, Continuous
|
58.49 years
STANDARD_DEVIATION 13.50 • n=99 Participants
|
59.58 years
STANDARD_DEVIATION 11.99 • n=107 Participants
|
58.97 years
STANDARD_DEVIATION 12.85 • n=206 Participants
|
|
Sex: Female, Male
Female
|
322 Participants
n=99 Participants
|
258 Participants
n=107 Participants
|
580 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
177 Participants
n=99 Participants
|
143 Participants
n=107 Participants
|
320 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=99 Participants
|
4 Participants
n=107 Participants
|
7 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
496 Participants
n=99 Participants
|
397 Participants
n=107 Participants
|
893 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Black or African American
|
228 Participants
n=99 Participants
|
142 Participants
n=107 Participants
|
370 Participants
n=206 Participants
|
|
Race (NIH/OMB)
White
|
257 Participants
n=99 Participants
|
250 Participants
n=107 Participants
|
507 Participants
n=206 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
14 Participants
n=99 Participants
|
9 Participants
n=107 Participants
|
23 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
499 participants
n=99 Participants
|
401 participants
n=107 Participants
|
900 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: The time frame will be whether they attended the referral appointment between the screening date until 6 months after the screening date.The percentage of patients who adhere to attending their referral appointments who received a financial incentive and eye health education will be compared with the percentage of patients who adhere to attending their referral appointments who received standard of care eye health education alone and no financial incentive for completing a referral visit.
Outcome measures
| Measure |
No Financial Incentive
n=499 Participants
This group will receive standard of care eye health education alone and no financial incentive for completing a referral visit.
No Financial Incentive: Standard of care eye health education
|
Financial Incentive
n=401 Participants
This group will receive a financial incentive once the referral visit is completed (if one was required) as well as eye health education.
Financial Incentive: Patients who are referred for an in-person follow-up exam will receive a financial incentive once the referral visit is completed.
|
|---|---|---|
|
Percentage of Participants That Adhere to Referral Appointment
|
80 Participants
|
92 Participants
|
Adverse Events
No Financial Incentive
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Financial Incentive
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place